Biotech Questions and Answers Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Questions and Answers

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Candle stick who wrote (16)	1/13/1999 8:31:00 PM
From: Mike McFarland	of 30

Good luck with Cortex...I owned that one for awhile too, even pulled a decent trade out of it...but finally decided that I had enough neuro stocks. I wonder what the reason could be for the CORX run up today--the hearing with Nasdaq is on Friday yes...maybe there is a rumor? (checking) Oh I see now, they have a partner for CX516 biz.yahoo.com ...then why only the run up 50%? I should have thought that was what everybody was waiting for? You know I don't think that there are that many clinical trial for Alzheimers going on, even less than for Parkinson's disease...I'm surprised it didn't at least double today. Oh and I see now that the deal is not for Alzheimers but for Schizophrenia and Depression, maybe that explains it--very competitive markets for those...not the holy grail. Still, with the partner, I should think they wont delist it...and if/when it stays listed on Nasdaq, then I'll bet it doubles. I beleive the other players with trials for Alzheimers are Elan, Neotherapeutics (NEOT), Neurocrine (NBIX), and the two I have, Sibia (SIBI) and Neurobiological Technologies/Merz (NTII). There are probably a few more--who can keep track! --Mike

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next